Tudor Investment Corp’s Esperion Therapeutics ESPR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-43,214	Closed	-$116K	–	2451
2024 Q1	$116K	Buy	+43,214	New	+$105K	﹤0.01%	2087
2023 Q4	–	Sell	-72,525	Closed	-$71.1K	–	2498
2023 Q3	$71.1K	Hold	72,525	–	–	﹤0.01%	2168
2023 Q2	$101K	Sell	72,525 -49,456	-41%	-$69.1K	﹤0.01%	2294
2023 Q1	$194K	Buy	121,981 +37,032	+44%	+$191K	﹤0.01%	2186
2022 Q4	$529K	Buy	84,949 +13,505	+19%	+$96.6K	0.01%	1547
2022 Q3	$479K	Buy	71,444 +25,547	+56%	+$175K	0.01%	1437
2022 Q2	$292K	Sell	45,897 -26,627	-37%	-$151K	0.01%	1585
2022 Q1	$337K	Buy	72,524 +168	+0.2%	+$721	0.01%	1491
2021 Q4	$362K	Buy	72,356 +1,785	+3%	+$14.3K	0.01%	1700
2021 Q3	$850K	Buy	70,571 +41,237	+141%	+$600K	0.01%	1268
2021 Q2	$620K	Hold	29,334	–	–	0.01%	1087
2021 Q1	$823K	Sell	29,334 -9,446	-24%	-$279K	0.02%	928
2020 Q4	$1.01M	Buy	38,780 +29,421	+314%	+$881K	0.03%	697
2020 Q3	$348K	Buy	+9,359	New	+$371K	0.02%	942
2019 Q3	–	Sell	-9,890	Closed	-$460K	–	1160
2019 Q2	$460K	Buy	9,890 +4,747	+92%	+$223K	0.01%	736
2019 Q1	$206K	Sell	5,143 -5,531	-52%	-$248K	0.01%	993
2018 Q4	$491K	Buy	+10,674	New	+$514K	0.01%	600
2017 Q4	–	Sell	-42,954	Closed	-$2.15M	–	1128
2017 Q3	$2.15M	Buy	+42,954	New	+$2.07M	0.05%	197
2015 Q4	–	Sell	-23,100	Closed	-$545K	–	1693
2015 Q3	$545K	Buy	+23,100	New	+$1.45M	0.02%	726
2015 Q2	–	Sell	-5,903	Closed	-$547K	–	1535
2015 Q1	$547K	Buy	+5,903	New	+$381K	0.02%	687
2013 Q4	–	Sell	-10,000	Closed	-$189K	–	1290
2013 Q3	$189K	Buy	+10,000	New	+$168K	0.01%	745

Other funds holding ESPR